Locations:

Tag: Immunosuppressive therapy

November 30, 2023/Rheumatology & Immunology/Immunologic Diseases

Skin Cancer Risk in Immunosuppressed Patients

Education, prevention strategies and monitoring serves this at-risk group

July 25, 2023/Rheumatology & Immunology/Immunologic Diseases

Case: Getting to the Root of Neuropathic Symptoms

Collaboration was key to identifying source of nerve condition

Pharmacist handing medications to patient

May 23, 2023/Neurosciences/Neuromuscular

What Are the Treatment Options for Myasthenia Gravis if First-Line Agents Fail?

Guidance for the 5% to 20% of patients with suboptimal response or tolerability

January 12, 2023/COVID-19

Real World Experience with Tixagevimab/Cilgavimab in B-Cell-Depleted Patients

Early results suggest positive outcomes from COVID-19 PrEP treatment

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

August 9, 2022/Rheumatology & Immunology/Immunologic Diseases

Case Study: EBV-Associated Primary CNS Lymphoma in a Patient on Long-Term Mycophenolate Mofetil

First reported case in a patient with diffuse cutaneous systemic sclerosis

650×450-Normal-marrow-and-aplastic-marrow-comparison

November 29, 2021/Pediatrics/Hematology & oncology

Improving Therapies for Children With Severe Aplastic Anemia

Combination therapy shows promise in pediatric patient population

BackPage 1 of 1Next